The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 2 study of cemiplimab, a human monoclonal anti-PD-1, in patients (pts) with metastatic cutaneous squamous cell carcinoma (mCSCC; Group 1): 12-month follow-up.
 
Alexander David Guminski
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; Merck; MSD Oncology; Pfizer; Prime Oncology; Regeneron; Sun Pharma
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Medivation/Astellas; Merck KGaA; Sun Pharma
 
Annette May Ling Lim
No Relationships to Disclose
 
Nikhil I. Khushalani
Stock and Other Ownership Interests - Amarin Corporation; Bellicum Pharmaceuticals; Mazor Robotics; Transenterix
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bristol-Myers Squibb; EMD Serono; Genentech; HUYA Bioscience International; Immunocore; Merck; Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); GlaxoSmithKline (Inst); HUYA Bioscience International (Inst); Merck (Inst); Novartis (Inst); Regeneron (Inst)
 
Chrysalyne D. Schmults
Consulting or Advisory Role - Regeneron
Research Funding - Genentech; Novartis; Regeneron
Other Relationship - Castle Biosciences
 
Leonel Fernando Hernandez-Aya
Consulting or Advisory Role - Massive Bio
Speakers' Bureau - Sanofi/Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Immunocore (Inst); MedImmune (Inst); Merck (Inst); Merck Serono (Inst); Polynoma (Inst); Regeneron (Inst); Roche/Genentech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Sanofi/Regeneron
 
Badri Modi
Employment - City of Hope
Speakers' Bureau - Regeneron; Sanofi
Travel, Accommodations, Expenses - Regeneron; Sanofi
 
Lara Dunn
Consulting or Advisory Role - Regeneron
Research Funding - Eisai; Pfizer; Regeneron
 
Brett Gordon Maxwell Hughes
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Eisai; MSD Oncology; Pfizer; Roche
Research Funding - Amgen (Inst)
 
Anne Lynn S. Chang
Consulting or Advisory Role - Merck; Regeneron
Research Funding - Galderma; Merck; Novartis; NS Pharma; Regeneron
Patents, Royalties, Other Intellectual Property - Epinomics and Accent Therapeutics (I)
 
Axel Hauschild
Honoraria - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Philogen; Provectus; Regeneron; Roche; Sanofi/Aventis
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Philogen; Provectus; Regeneron; Roche; Sanofi/Aventis
Research Funding - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Regeneron; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Novartis; Roche; Sanofi/Aventis
 
Michael Robert Migden
Honoraria - Regeneron; Sanofi; Sun Pharma
Consulting or Advisory Role - Regeneron; Sanofi; Sun Pharma
Research Funding - Regeneron; Sanofi
Travel, Accommodations, Expenses - Regeneron; Sanofi; Sun Pharma
 
Ralf Gutzmer
Honoraria - Almirall Hermal GmbH; Amgen; AstraZeneca; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dome; Novartis; Pierre Fabre; Regeneron; Roche/Genentech; Sanofi; Sun Pharma
Consulting or Advisory Role - 4SC; Almirall Hermal GmbH; Amgen; Bristol-Myers Squibb; Incyte; LEO Pharma; Merck Serono; Merck Sharp & Dome; Novartis; Pierre Fabre; Roche/Genentech; Sun Pharma; Takeda
Research Funding - Amgen (Inst); Johnson & Johnson (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck Serono; Pierre Fabre; Roche
 
Murad Alam
Consulting or Advisory Role - Pulse Biosciences; Revance Therapeutics
 
Vladimir Jankovic
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Elizabeth Stankevich
Employment - Regeneron
Stock and Other Ownership Interests - Bristol-Myers Squibb; Celgene; Merck; Regeneron
 
Jocelyn Booth
Employment - Alnylam (I); Regeneron
Stock and Other Ownership Interests - Alnylam (I); Celgene (I); Regeneron; Regeneron (I)
 
Siyu Li
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Israel Lowy
Employment - Regeneron
Stock and Other Ownership Interests - Regeneron
 
Matthew G. Fury
Employment - Regeneron; Regeneron (I)
Stock and Other Ownership Interests - Regeneron; Regeneron (I)
Consulting or Advisory Role - Egenix
Research Funding - AstraZeneca/MedImmune; Novartis; Regeneron
Patents, Royalties, Other Intellectual Property - Regeneorn; Regeneron (I)
 
Danny Rischin
Research Funding - Amgen; Bristol-Myers Squibb; Genentech/Roche; GlaxoSmithKline; Merck; Regeneron